Igm-2644, a Novel CD38xCD3 Bispecific IgM T Cell Engager Demonstrates Potent Efficacy on Myeloma Cells with an Improved Preclinical Safety Profile

Autor: Li, Keyu *, Yun, Rui *, Chai, Min *, Yakkundi, Poonam *, Rosete, Rodnie *, Li, Gene *, Liu, Liqin *, Ng, Dean *, Hinton, Paul R. *, Kotturi, Maya F. *, Sinclair, Angus M., Carroll, Stephen F. *, Muchhal, Umesh *, Keyt, Bruce A.
Zdroj: In Blood 15 November 2022 140 Supplement 1:6010-6011
Databáze: ScienceDirect